CD8A and metabolic dysfunction-associated steatohepatitis: Moreover, there is evidence that Metformin therapy restores the impaired metabolic function of hepatic CD8+ T cells in non-alcoholic steatohepatitis (NASH) and enhances the efficacy of anti-PD-1 treatment in liver tumors associated with NASH [465].